Beta blocker therapy for chronic heart failure

American Family Physician

Volumn 62, Issue 10, 2000, Pages 2267-2274

  Ramahi, Tarik M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL FUMARATE; CARVEDILOL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; INOTROPIC AGENT; LABETALOL; METOPROLOL; MILRINONE; PHOSPHODIESTERASE INHIBITOR; PROPRANOLOL; SPIRONOLACTONE;

ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; HEART FAILURE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MORTALITY; PATIENT SELECTION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; CHRONIC DISEASE; DECISION TREES; DRUG THERAPY, COMBINATION; HEART FAILURE, CONGESTIVE; HUMANS; PATIENT SELECTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034669099     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group
2. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise
3. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group
4. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators
5. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group
6. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
7. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised intervention Trial in Congestive Heart Failure (MERIT-HF)
8. Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials
9. Effects of enalapril on mortality in severe congestive heart failure Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) The CONSENSUS Trial Study Group
10. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart fairure
11. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.The SOLVD Investigators
12. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators
13. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
14. Consensus recommendations for the management of chronic heart failure
15. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group
16. Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol teatment followed by withdrawal and readministration of metoprolol